Heart failure contributes to Duchenne muscular dystrophy (DMD), which arises from
mutations that ablate dystrophin, rendering the plasma membrane prone to disruption …

In clinical practice and research, innovative digital technologies have been proposed for the
characterization of neuromuscular and movement disorders through objective measures …

Classifying gait patterns into homogeneous groups could enhance communication among
healthcare providers, clinical decision making and clinical trial designs in boys with …

Background Multiple clinical trials to assess the efficacy of AAV-directed gene transfer in
participants with Duchenne muscular dystrophy (DMD) are ongoing. The success of these …

Background: Duchenne muscular dystrophy (DMD) is a neuromuscular disorder that affects
ambulatory function. Quantitative ultrasound (QUS) imaging, utilizing envelope statistics, has …

Objectives Ataluren and eteplirsen are orphan drugs that delay progression of Duchenne
muscular dystrophy in mutation-specific subgroups. They have yet to be approved in Egypt …

Мышечная дистрофия Дюшенна-генетическое орфанное нервно-мышечное
заболевание, обусловленное мутацией гена DMD, кодирующего белок дистрофин. В …

Duchenne muscular dystrophy (DMD) is a neuromuscular condition characterized by muscle
weakness. The Performance of upper limb (PUL) test is designed to evaluate upper limb …

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are two rare
genetic disorders of the family dystrophinopathy. They are both caused by the lack of, or …

Наследствените неврологични заболявания представляват широка хетерогенна група
от болести, които засягат главния и гръбначния мозък, мускулите и нервите. По-голяма …